Regeneron Pharmaceuticals, Inc.REGNNASDAQ
LOADING
|||
Gross Profit Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
2.78%
↓ 42% below average
Average (39q)
4.77%
Historical baseline
Range
High:103.12%
Low:-36.17%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 2.78% |
| Q2 2025 | 22.66% |
| Q1 2025 | -20.45% |
| Q4 2024 | -0.18% |
| Q3 2024 | 5.31% |
| Q2 2024 | 13.12% |
| Q1 2024 | -3.35% |
| Q4 2023 | -0.56% |
| Q3 2023 | 6.45% |
| Q2 2023 | 1.73% |
| Q1 2023 | -10.40% |
| Q4 2022 | 15.11% |
| Q3 2022 | 1.61% |
| Q2 2022 | -0.01% |
| Q1 2022 | -36.17% |
| Q4 2021 | 33.09% |
| Q3 2021 | -33.09% |
| Q2 2021 | 103.12% |
| Q1 2021 | 7.23% |
| Q4 2020 | 2.42% |
| Q3 2020 | 21.20% |
| Q2 2020 | 4.05% |
| Q1 2020 | -2.06% |
| Q4 2019 | 8.34% |
| Q3 2019 | 6.19% |
| Q2 2019 | 20.04% |
| Q1 2019 | -34.98% |
| Q4 2018 | 16.48% |
| Q3 2018 | 2.36% |
| Q2 2018 | 9.01% |
| Q1 2018 | -5.68% |
| Q4 2017 | 6.14% |
| Q3 2017 | 2.00% |
| Q2 2017 | 11.31% |
| Q1 2017 | 6.54% |
| Q4 2016 | -2.16% |
| Q3 2016 | 0.39% |
| Q2 2016 | 5.00% |
| Q1 2016 | 10.32% |
| Q4 2015 | -4.00% |